5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.12▲ | 3.03▲ | 3.02▲ | 2.90▲ | 2.74▲ |
MA10 | 2.99▲ | 2.92▲ | 2.90▲ | 2.72▲ | 2.60▲ |
MA20 | 2.89▲ | 2.85▲ | 2.83▲ | 2.62▲ | 2.35▲ |
MA50 | 2.70▲ | 2.67▲ | 2.67▲ | 2.49▲ | 3.67▼ |
MA100 | 2.69▲ | 2.67▲ | 2.66▲ | 2.35▲ | N/A |
MA200 | 2.63▲ | 2.50▲ | 2.44▲ | 2.90▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.034▲ | 0.036▲ | 0.039▲ | 0.062▲ | N/A |
RSI | 81.236▲ | 78.382▲ | 77.748▲ | 75.662▲ | N/A |
STOCH | 99.444▲ | 99.603▲ | 99.603▲ | 94.370▲ | 72.759 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -0.200▲ | -0.152▲ |
CCI | 142.242▲ | 205.915▲ | 204.887▲ | 206.317▲ | 169.448▲ |
Monday, December 21, 2020 04:00 PM
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and oncology ...
|
Monday, December 21, 2020 04:00 PM
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach ...
|
Thursday, December 10, 2020 05:25 AM
Aptorum Group Limited (Nasdaq: APM; Euronext Paris: APM) (the “Company”, “Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/01/21 | 2.91 | 3.312 | 2.80 | 3.31 | 860,700 |
14/01/21 | 2.75 | 2.85 | 2.71 | 2.85 | 174,600 |
13/01/21 | 2.78 | 2.82 | 2.65 | 2.74 | 93,600 |
12/01/21 | 2.79 | 2.85 | 2.70 | 2.82 | 189,700 |
11/01/21 | 2.69 | 2.80 | 2.65 | 2.79 | 171,056 |
08/01/21 | 2.60 | 2.71 | 2.579 | 2.70 | 292,500 |
07/01/21 | 2.45 | 2.62 | 2.45 | 2.54 | 163,900 |
06/01/21 | 2.50 | 2.56 | 2.425 | 2.45 | 140,300 |
05/01/21 | 2.49 | 2.54 | 2.42 | 2.48 | 119,903 |
04/01/21 | 2.51 | 2.60 | 2.45 | 2.48 | 194,315 |
|
|
||||
|
|
||||
|
|